ACCPL
Start SIP
Invest Now
Start SIP in ACCPL
Performance
- Low
- ₹68
- High
- ₹68
- 52 Week Low
- ₹54
- 52 Week High
- ₹103
- Open Price₹68
- Previous Close₹68
- Volume2,400
- 50 DMA₹73.98
- 100 DMA₹73.34
- 200 DMA-
Investment Returns
- Over 1 Month -12.35%
- Over 3 Month + 13%
- Over 6 Month + 12.44%
- Over 1 Year -32.87%
Smart Investing Starts Here Start SIP with Accretion Pharmaceuticals for Steady Growth!
Accretion Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.1
- PEG Ratio
- -
- Market Cap Cr
- 75
- P/B Ratio
- 1.6
- Average True Range
- 2.82
- EPS
- 6.11
- Dividend Yield
- 0
- MACD Signal
- -3.29
- RSI
- 41.6
- MFI
- 63.47
Accretion Pharmaceuticals Financials
Accretion Pharmaceuticals Technicals
EMA & SMA
Current Price
₹67.80
-0.6
(-0.88%)
- Bearish Moving Average 14
- Bullish Moving Average 0
- 20 Day
- ₹70.51
- 50 Day
- ₹73.98
- 100 Day
- ₹73.34
- 200 Day
- -
Resistance and Support
67.82
- R3 67.88
- R2 67.87
- R1 67.83
- S1 67.78
- S2 67.77
- S3 67.73
Accretion Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-06-10 | Audited Results & Others | To consider Other business matters. |
Accretion Pharmaceuticals F&O
About Accretion Pharmaceuticals
- NSE Symbol
- ACCPL
- BSE Symbol
- Managing Director
- Mr. Vivek Ashok Kumar Patel
- ISIN
- INE0T8T01010
Similar Stocks to Accretion Pharmaceuticals
Accretion Pharmaceuticals FAQs
Accretion Pharmaceuticals share price is ₹67 As on 12 February, 2026 | 11:18
The Market Cap of Accretion Pharmaceuticals is ₹75.4 Cr As on 12 February, 2026 | 11:18
The P/E ratio of Accretion Pharmaceuticals is 11.1 As on 12 February, 2026 | 11:18
The PB ratio of Accretion Pharmaceuticals is 1.6 As on 12 February, 2026 | 11:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.